Anti-CYB561D2 monoclonal antibody

Pre-made anti-CYB561D2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CYB561D2/CYB561D2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0638-Ab-1/ GM-Tg-hg-IP0638-Ab-2Anti-Human CYB561D2 monoclonal antibodyHuman
GM-Tg-rg-IP0638-Ab-1/ GM-Tg-rg-IP0638-Ab-2Anti-Rat CYB561D2 monoclonal antibodyRat
GM-Tg-mg-IP0638-Ab-1/ GM-Tg-mg-IP0638-Ab-2Anti-Mouse CYB561D2 monoclonal antibodyMouse
GM-Tg-cynog-IP0638-Ab-1/ GM-Tg-cynog-IP0638-Ab-2Anti-Cynomolgus/ Rhesus macaque CYB561D2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0638-Ab-1/ GM-Tg-felg-IP0638-Ab-2Anti-Feline CYB561D2 monoclonal antibodyFeline
GM-Tg-cang-IP0638-Ab-1/ GM-Tg-cang-IP0638-Ab-2Anti-Canine CYB561D2 monoclonal antibodyCanine
GM-Tg-bovg-IP0638-Ab-1/ GM-Tg-bovg-IP0638-Ab-2Anti-Bovine CYB561D2 monoclonal antibodyBovine
GM-Tg-equg-IP0638-Ab-1/ GM-Tg-equg-IP0638-Ab-2Anti-Equine CYB561D2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0638-Ab-1/ GM-Tg-hg-IP0638-Ab-2; GM-Tg-rg-IP0638-Ab-1/ GM-Tg-rg-IP0638-Ab-2;
GM-Tg-mg-IP0638-Ab-1/ GM-Tg-mg-IP0638-Ab-2; GM-Tg-cynog-IP0638-Ab-1/ GM-Tg-cynog-IP0638-Ab-2;
GM-Tg-felg-IP0638-Ab-1/ GM-Tg-felg-IP0638-Ab-2; GM-Tg-cang-IP0638-Ab-1/ GM-Tg-cang-IP0638-Ab-2;
GM-Tg-bovg-IP0638-Ab-1/ GM-Tg-bovg-IP0638-Ab-2; GM-Tg-equg-IP0638-Ab-1/ GM-Tg-equg-IP0638-Ab-2
Products NameAnti-CYB561D2 monoclonal antibody
Formatmab
Target NameCYB561D2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CYB561D2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0638-Ag-1Recombinant multi-species C56D2/ CYB561D2/ 101F6 protein
    ORF Viral VectorvGMLP000013human CYB561D2 Lentivirus particle
    ORF Viral VectorpGMLP000013human CYB561D2 Lentivirus plasmid


    Target information

    Target IDGM-IP0638
    Target NameCYB561D2
    Gene ID11068,56368,363137,702280,484759,101095404,523966,100061714
    Gene Symbol and Synonyms101F6,CYB561D2,LOC100061714,LOC101095404,TSP10,XXcos-LUCA11.4
    Uniprot AccessionO14569,Q641Y1,Q5E965
    Uniprot Entry NameC56D2_HUMAN,C56D2_RAT,C56D2_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000114395
    Target ClassificationN/A

    The target: CYB561D2, gene name: CYB561D2, also named as 101F6, TSP10, XXcos-LUCA11.4. Enables heme binding activity and transmembrane monodehydroascorbate reductase activity. Involved in ascorbate homeostasis. Predicted to be located in vesicle. Predicted to be active in endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.